| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/19/2004 | WO2004069812A1 Pyrimidine derivatives for the prevention of hiv infection |
| 08/19/2004 | WO2004069808A1 Acrylamide derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069778A1 Antimicrobial trinervitane derivatives |
| 08/19/2004 | WO2004069280A1 Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent |
| 08/19/2004 | WO2004069261A1 Process for producing antiherpesvirus preparation for external use |
| 08/19/2004 | WO2004069255A2 Use of quinazoline derivatives or other compounds for inhibiting dihydrofolate reduxtase; screening assay for the identification of novel therapeutics and their cellular targets |
| 08/19/2004 | WO2004069253A1 Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones |
| 08/19/2004 | WO2004069251A1 Regimen of administration for nelfinavir |
| 08/19/2004 | WO2004069245A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
| 08/19/2004 | WO2004069244A1 Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents |
| 08/19/2004 | WO2004069235A1 The use of sodium 2-mercaptoethanesulfonate as antiviral agent |
| 08/19/2004 | WO2004069196A2 Novel compounds |
| 08/19/2004 | WO2004069184A2 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2004069140A2 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 08/19/2004 | WO2004069134A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 08/19/2004 | WO2004056828A3 Novel compounds and uses thereof |
| 08/19/2004 | WO2004054356A3 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 08/19/2004 | WO2004048320B1 Biguanide and dihydrotriazine derivatives |
| 08/19/2004 | WO2004046196A3 Compositions and methods for treating bacterial infections with protein-dalbavancin complexes |
| 08/19/2004 | WO2004041201A3 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/19/2004 | WO2004019912A3 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 08/19/2004 | WO2004016632B1 Lincomycin derivatives possessing antibacterial activity |
| 08/19/2004 | WO2003093258A3 Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases |
| 08/19/2004 | WO2003092585A3 Controlled release compositions of estradiol metabolites |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |
| 08/19/2004 | WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2003049117A3 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 08/19/2004 | WO2002092006A3 Nucleic acid-based compounds and methods of use thereof |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162430 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162313 Heterocyclic derivatives |
| 08/19/2004 | US20040162279 Tricyclic tetrahydroquinoline antibacterial agents |
| 08/19/2004 | US20040162277 Anhydrous crystal of beta-lactam compound and method for preparation thereof |
| 08/19/2004 | US20040162271 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 08/19/2004 | US20040162265 Polymorphism crystal structure; stability |
| 08/19/2004 | US20040162254 Antiviral oligonucleotides targeting HSV and CMV |
| 08/19/2004 | US20040162253 Administering pharmacologically acceptable oligonucleotide at least 10 nucleotides in length, wherein the anti-HBV activity of oligonucleotide occurs principally by a non-sequence complementary mode of action |
| 08/19/2004 | US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV |
| 08/19/2004 | US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161477 Plant extracts such as gallotannins; prevent reproduction of virus |
| 08/19/2004 | US20040161432 Subunit vaccines and processes for the production thereof |
| 08/19/2004 | US20040161420 Designed for bacterial live vector vaccines; does not rely on antibiotic resistance; stability |
| 08/19/2004 | US20040161415 Inducted heat shock proteins in activated lymphocytes |
| 08/19/2004 | US20040161411 Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense system |
| 08/19/2004 | US20040161405 Guanidinium transport reagents and conjugates |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2516942A1 Use of quinazoline derivatives or other compounds for inhibiting dihydrofolate reduxtase; screening assay for the identification of novel therapeutics and their cellular targets |
| 08/19/2004 | CA2515311A1 Antibacterial agents |
| 08/19/2004 | CA2515269A1 Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents |
| 08/19/2004 | CA2515123A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515122A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2515095A1 Regimen of administration for nelfinavir |
| 08/19/2004 | CA2515070A1 Novel compounds |
| 08/19/2004 | CA2514576A1 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514270A1 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/19/2004 | CA2514241A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
| 08/19/2004 | CA2506619A1 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/18/2004 | EP1447451A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND-BETA2m AND UTILIZATION THEREOF |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447398A1 Retroviral protease inhibitors |
| 08/18/2004 | EP1447397A1 Polyfunctional sulfonamides and sulfonates and process for preparing them |
| 08/18/2004 | EP1447094A1 Remedies for pruritus |
| 08/18/2004 | EP1447086A1 An aqueous metal bicarbonate solution and method of use |
| 08/18/2004 | EP1447083A1 Preventives/remedies for viral infection |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446425A2 Treatment of micro-organism infection |
| 08/18/2004 | EP1446422A2 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/18/2004 | EP1446420A2 Virulence proteins of the genus yersinia and uses thereof |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446412A2 Novel lna compositions and uses thereof |
| 08/18/2004 | EP1446405A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/18/2004 | EP1446403A1 Aryl substituted oxazolidinones with antibacterial activity |
| 08/18/2004 | EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446391A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 08/18/2004 | EP1446170A1 Medical devices having antimicrobial coatings thereon |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446159A2 Immunotherapy for reversing immune suppression |
| 08/18/2004 | EP1446142A1 Potentiating the therapeutic effects of interferons |
| 08/18/2004 | EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446126A1 Coated particulate cefuroxime axetil compositions |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1446106A2 Optimal polymer mixtures for gastric retentive tablets |
| 08/18/2004 | EP1446104A1 Spray drying methods and compositions thereof |
| 08/18/2004 | EP1446103A2 Injectable compositions for the controlled delivery of pharmacologically active compound |